Life Sciences & Biotech
- For decades California has had an excellent track record of pioneering the work in Life Sciences innovation and producing thousands of new therapies and technologies in this field.
- Within California, the San Francisco Bay Area claims the largest cluster of biotech companies with nearly 25% of all Life Sciences employment in California in 2015.
- There are currently 2848 life sciences companies in California, which has increased by 212 companies from 2014. Most companies are small, entrepreneurial start-ups by nature, built on innovative technologies.
- At present there are 1235 new therapies being tried and tested in California. Nearly 30% of these new products are cancer-related.
- In Q4 2015, the Biotech sector employed 1,867 employers in San Francisco County, and employed 172,000 workers in the San Francisco Metropolitan area. This figure is nearly 20% of the total jobs created in California. For the Bay Area, the Life Sciences & Biotech sector generated $95 billion of economic activity, nearly $30 billion in income, and added 300,073 jobs.
- The San Francisco Bay Area is home to more than 25 venture capital funded Biotech companies, including Proteus Digital Health Inc., Versartis Inc., Coherus Biosciences Inc., VoloAgri Inc., and Avalanche Biotechnologies Inc.
- California continues to attract interest and investment of many companies throughout the world thanks to the discoveries and innovations made in life sciences. This flow of investment means that in 2015 California attracted more than $4.7 billion, a sharp increase from the $3.6 billion received in 2014.
- Within California, in Q4 2015, the San Francisco Bay Area came in as a close runner-up to front runner, Boston, capturing $839 million in VC investment. San Francisco also secured a position in the top 5 cities with the highest biotech investment. New York, The Research Triangle and Chicago secured the other places.
- California attracted just over 50% more VC investment than Massachusetts, the 2nd biggest attractor of VC investment and nearly 100% more than the 10th biggest state, Connecticut.
- California continues to dominate the nation is academic achievement. According to the Shanghai Index, California has 11 of the world’s top 100 schools. New York is the next closest with five. In 2013, academic institutions in the state awarded 4,966 doctorates to scientists and engineers. By contrast, the second highest state, New York, awarded 2,985.
- In labs throughout the state, California’s academic researchers attract billions of dollars in grants from the National Institutes of Health (NIH) and other entities. In 2015, California institutions received more than 7,328 awards/grants, totaling $3.3 billion, a 15% share of all NIH grants distributed. Among California institutions UCSF, UC San Diego and Stanford lead the pack, bringing in a combined $1.31 billion of NIH funding.
- Specifically, the Bay Area is home to the largest aggregation of research universities and federal research institutions in the U.S; in fact, Bay Area universities produce more Ph.D. scientists & engineers than any other area in the whole of the US!
- UCSF’s Mission Bay campus, a bio-entrepreneurship center, offers mentoring and training for faculty members whose discoveries might form the basis of spin-off innovations. In addition, the Mission Bay Campus provides funding and state-of-the-art technology, including telemedicine, robotics and intra-operative imaging, as well as space to accommodate tomorrow’s innovations.
World Class Life Sciences Incubators
- San Francisco continues to be the heart of biotechnology in the surrounding Bay area. The transformation of UCSF’s Mission Bay into a thriving biotechnology center has brought a significant economic advantage for San Francisco.
- Since 2006, Mission Bay has nurtured hundreds of life science or medical technology startups, most of them hatching in incubator programs that vary widely in size, duration, scientific focus and financial investment.
- By Q4 2015, more than 10 incubators have given rise to nearly 100 early-stage companies. In addition to QB3 UCSF and QB3 Berkeley, some more recent incubators such as Illumina, TheraNova and FibroGen are also accelerating the growth of many startups.
- Also located in Mission Bay are the U.S. Innovation Center (USIC) and Bayer’s CoLaborator, a 6,000-square-foot incubator space for start-ups, both opened by Bayer Healthcare in 2011.
- UCSF receives nearly a quarter of all NIH funding in California.
- Mission Bay, the hub of San Francisco’s life sciences industry, spans 303 acres in the heart of the burgeoning and dynamic South of Market area. This hub of knowledge and innovation is also home to prominent private sector companies, including: Celgene Corp, Presidio Pharmaceuticals, Inc., FibroGen, Ion Torrent Systems, Inc., Bayer, Pfizer and Nextar.
- Mission Bay accommodates 6,000 units of housing (28 percent affordable), 4.4 million square feet of office and R&D space, a 57-acre UCSF research campus and 550-bed medical center, 500,000 square feet of retail, a 500 room hotel, 49 acres of new public open space, a new 500-student public school, a new public library, a new fire and police stations and other community facilities.
- Alexandria Real Estate Equities, the preeminent international developer of life science-focused properties, added 155,000 square feet of move-in ready, turnkey labs/office suites, with an additional 300,000 square feet of space.
- Mission Bay has recently announced that 3 new projects that will be undertaken: Block 33 Building, Block 23A Building and Mission Hall.
- More than 80 percent new and under construction life-science inventory in the Bay Area is located in San Francisco and San Mateo counties with already more than 35 percent of life science real estate located in the city of South San Francisco alone.
- Other areas of the City offer attractive opportunities as well, including the nearby Financial District and South of Market area.
Additional Data is Available Online
California Life Sciences Institute The California Life Sciences Institute (CLSI) strives to ensure that the economic and intellectual power of the region’s life sciences industry and its employees remains strong. By maintaining focus on entrepreneurship, education and career development programs, CLSI supports the foundations of innovation that have made California home to the world’s most prominent life sciences ecosystem.
The Money Tree Report The Money Tree Report is a study about Venture Capital Investment in the United States carried out collaboratively by PricewaterhouseCoopers and the National Venture Capital Association based upon data from Thomson Reuters. They provide very current regional numbers about capital investment in key industries.
California Life Sciences Association The Life Sciences Association California Life Sciences Association (CLSA) is the leading voice for California’s life sciences sector. CLSA works closely with industry, government, academia and other stakeholders to shape public policy, drive business solutions and grow California’s life sciences innovation ecosystem. CLSA serves over 750 biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors and service providers. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged to create the state’s most influential life sciences advocacy and business leadership organization.